---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40063174.md"
description: "BeiGene and Akeso Biopharma are basically flat, RemeGen fell 2.5%, the overall Hong Kong stock innovative drug sector is weak this round: it's time to wait for earnings verification 🫥"
datetime: "2026-04-21T11:08:47.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40063174.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40063174.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40063174.md)
author: "[我先笑为敬](https://longbridge.com/en/profiles/27014614.md)"
---

# BeiGene and Akeso Biopharma are basically flat, Re…


### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)